BCR C.R. Bard, Inc.

  • STOCK
  • BCR
  • Price as of: Dec 22, 05:00 PM EST
  • $169.51
  • +$0.01
  • +0.0%
  • Industry
  • Medical instruments & supplies
Share

BCR Stock Dividend Data

Add BCR to Watchlist
  • Dividend Yield
    0.52% Healthcare Average 2.29%
  • Annual Payout
    $0.88 Paid Quarterly
  • Payout Ratio
    10.5% EPS $8.36
  • Dividend Growth
    42 yrs Since 1972
  • Get BCR DARS™ Rating
DARS Rating™ Breakdown

Dividend.com DARS Rating™ Breakdown for BCR

Sign Up
Metric BCR Rank BCR Avg Ranking Notes
Relative Strength Sign Up For Ticker Ranking Sign Up For Sector Ranking Stock is breaking to the upside.
Overall Yield Attractiveness Sign Up For Ticker Ranking Sign Up For Sector Ranking Stock's dividend yield is adequate.
Dividend Reliability Sign Up For Ticker Ranking Sign Up For Sector Ranking This rating is related to the length and consistency of a company's dividend payouts, as well as our opinion on how likely the company is to continue payouts in the future.
Dividend Uptrend Sign Up For Ticker Ranking Sign Up For Sector Ranking Dividend payouts are consistent, but increases small.
Earnings Growth Sign Up For Ticker Ranking Sign Up For Sector Ranking Earnings estimates are uptrending.
DARS Rating Sign Up For Ticker Ranking Sign Up For Sector Ranking Sign Up For DARS Ratings
Growth History

BCR Dividend Growth History

Annualized Growth
1994-2012
Annualized Growth
1994-2004
Annualized Growth
2004-2008
Annualized Growth
2008-2012
Annualized Growth
Last 5 Yrs
Annualized Growth
Last 3 Yrs
Annual
Growth
2012
Consecutive
Years of
Increases
Reveal More Dividend Growth History for BCR 5.4% 5.1% 42 years
Reveal More Dividend Growth History for BCR
Historical Annual Dividend Data & Growth

BCR Historical Annual Dividend Data & Growth

Payout Amount Calendar Year Annual Growth
$0.8200 2013 5.1%
Historical Dividend Data

BCR Dividend History

Payout Amount Declared Date Ex-Dividend Date Record Date Pay Date ▼ Qualified Dividend? Payout Type Frequency
$0.2200 2014-12-10 2015-01-22 2015-01-26 2015-02-06 Yes Regular Quarter
$0.2200 2014-10-08 2014-10-16 2014-10-20 2014-10-31 Yes Regular Quarter
$0.2200 2014-06-11 2014-07-17 2014-07-21 2014-08-01 Yes Regular Quarter
$0.2100 2014-04-16 2014-04-24 2014-04-28 2014-05-09 Yes Regular Quarter
$0.2100 2013-12-11 2014-01-16 2014-01-21 2014-01-31 Yes Regular Quarter
$0.2100 2013-10-09 2013-10-17 2013-10-21 2013-11-01 Yes Regular Quarter
$0.2100 2013-06-12 2013-07-18 2013-07-22 2013-08-02 Yes Regular Quarter
$0.2000 2013-04-17 2013-04-25 2013-04-29 2013-05-10 Yes Regular Quarter
$0.2000 2012-12-12 2013-01-17 2013-01-22 2013-02-01 Yes Regular Quarter
$0.2000 2012-10-10 2012-10-18 2012-10-22 2012-11-02 Yes Regular Quarter
$0.2000 2012-06-13 2012-07-19 2012-07-23 2012-08-03 Yes Regular Quarter
$0.1900 2012-04-18 2012-04-26 2012-04-30 2012-05-11 Yes Regular Quarter
$0.1900 2011-12-14 2012-01-19 2012-01-23 2012-02-03 Yes Regular Quarter
$0.1900 2011-10-12 2011-10-20 2011-10-24 2011-11-04 Yes Regular Quarter
$0.1900 2011-06-08 2011-07-21 2011-07-25 2011-08-05 Yes Regular Quarter
$0.1800 2011-04-20 2011-04-28 2011-05-02 2011-05-13 Yes Regular Quarter
$0.1800 2010-12-08 2011-01-20 2011-01-24 2011-02-04 Yes Regular Quarter
$0.1800 2010-10-13 2010-10-21 2010-10-25 2010-11-05 Yes Regular Quarter
$0.1800 2010-06-09 2010-07-22 2010-07-26 2010-08-06 Yes Regular Quarter
$0.1700 2010-04-21 2010-04-29 2010-05-03 2010-05-14 Yes Regular Quarter
$0.1700 2009-12-09 2010-01-21 2010-01-25 2010-02-05 Yes Regular Quarter
$0.1700 2009-10-14 2009-10-22 2009-10-26 2009-11-06 Yes Regular Quarter
$0.1700 2009-06-10 2009-07-16 2009-07-20 2009-07-31 Yes Regular Quarter
$0.1600 2009-04-15 2009-04-23 2009-04-27 2009-05-08 Yes Regular Quarter
$0.1600 2008-12-10 2009-01-22 2009-01-26 2009-02-06 Yes Regular Quarter
$0.1600 2008-10-08 2008-10-16 2008-10-20 2008-10-31 Yes Regular Quarter
$0.1600 2008-06-11 2008-07-17 2008-07-21 2008-08-01 Yes Regular Quarter
$0.1500 2008-04-16 2008-04-24 2008-04-28 2008-05-09 Yes Regular Quarter
$0.1500 2007-12-12 2008-01-16 2008-01-21 2008-02-01 Yes Regular Quarter
$0.1500 2007-10-10 2007-10-18 2007-10-22 2007-11-02 Yes Regular Quarter
$0.1500 2007-06-13 2007-07-19 2007-07-23 2007-08-03 Yes Regular Quarter
$0.1400 2007-04-18 2007-04-26 2007-04-30 2007-05-11 Yes Regular Quarter
$0.1400 2006-12-13 2007-01-18 2007-01-22 2007-02-02 Yes Regular Quarter
$0.1400 2006-10-11 2006-10-19 2006-10-23 2006-11-03 Yes Regular Quarter
$0.1400 2006-06-14 2006-07-20 2006-07-24 2006-08-04 Yes Regular Quarter
$0.1300 2006-04-19 2006-04-27 2006-05-01 2006-05-12 Yes Regular Quarter
$0.1300 2005-12-14 2006-01-19 2006-01-23 2006-02-03 Yes Regular Quarter
$0.1300 2005-10-12 2005-10-20 2005-10-24 2005-11-04 Yes Regular Quarter
$0.1300 2005-06-08 2005-07-21 2005-07-25 2005-08-05 Yes Regular Quarter
$0.1200 2005-04-20 2005-04-28 2005-05-02 2005-05-13 Yes Regular Quarter
$0.1200 2004-12-10 2005-01-20 2005-01-24 2005-02-04 Yes Regular Quarter
$0.1200 2004-10-13 2004-10-21 2004-10-25 2004-11-05 Yes Regular Quarter
$0.1200 2004-07-14 2004-07-22 2004-07-26 2004-08-06 Yes Regular Quarter
2-for-1 2004-04-21 2004-06-01 2004-05-17 2004-05-28 NM Stock Split NM
$0.1150 2004-04-21 2004-04-29 2004-05-03 2004-05-14 Yes Regular Quarter
$0.1150 2003-12-10 2004-01-14 2004-01-19 2004-01-30 Yes Regular Quarter
$0.1150 2003-10-08 2003-10-16 2003-10-20 2003-10-31 Yes Regular Quarter
$0.1150 2003-07-09 2003-07-17 2003-07-21 2003-08-01 Yes Regular Quarter
$0.1100 2003-04-16 2003-04-24 2003-04-28 2003-05-09 Yes Regular Quarter
$0.1100 2002-12-11 2003-01-15 2003-01-20 2003-01-31 Yes Regular Quarter
$0.1100 2002-10-09 2002-10-17 2002-10-21 2002-11-01 Unknown Regular Quarter
$0.1100 2002-07-10 2002-07-18 2002-07-22 2002-08-02 Unknown Regular Quarter
$0.1050 2002-04-17 2002-04-25 2002-04-29 2002-05-10 Unknown Regular Quarter
$0.1050 2001-12-12 2002-01-16 2002-01-21 2002-02-01 Unknown Regular Quarter
$0.1050 2001-10-10 2001-10-18 2001-10-22 2001-11-02 Unknown Regular Quarter
$0.1050 2001-07-11 2001-07-19 2001-07-23 2001-08-03 Unknown Regular Quarter
$0.1050 2001-04-18 2001-04-26 2001-04-30 2001-05-11 Unknown Regular Quarter
$0.1050 2000-12-13 2001-01-18 2001-01-22 2001-02-02 Unknown Regular Quarter
$0.1050 2000-10-11 2000-10-19 2000-10-23 2000-11-03 Unknown Regular Quarter
$0.1050 2000-07-12 2000-07-20 2000-07-24 2000-08-04 Unknown Regular Quarter
$0.1000 2000-04-19 2000-04-27 2000-05-01 2000-05-12 Unknown Regular Quarter
$0.1000 1999-12-08 2000-01-20 2000-01-24 2000-02-04 Unknown Regular Quarter
$0.1000 1999-10-13 1999-10-21 1999-10-25 1999-11-05 Unknown Regular Quarter
$0.1000 1999-07-14 1999-07-22 1999-07-26 1999-08-06 Unknown Regular Quarter
$0.0950 1999-04-21 1999-04-29 1999-05-03 1999-05-14 Unknown Regular Quarter
$0.0950 1998-12-09 1999-01-21 1999-01-25 1999-02-05 Unknown Regular Quarter
$0.0950 1998-10-14 1998-10-22 1998-10-26 1998-11-06 Unknown Regular Quarter
$0.0950 1998-07-08 1998-07-16 1998-07-20 1998-07-31 Unknown Regular Quarter
$0.0900 1998-04-15 1998-04-23 1998-04-27 1998-05-08 Unknown Regular Quarter
$0.0900 1997-12-01 1998-01-22 1998-01-26 1998-02-06 Unknown Regular Quarter
$0.0900 1997-10-08 1997-10-16 1997-10-20 1997-10-31 Unknown Regular Quarter
$0.0900 1997-07-09 1997-07-17 1997-07-21 1997-08-01 Unknown Regular Quarter
$0.0850 1997-04-16 1997-04-24 1997-04-28 1997-05-09 Unknown Regular Quarter
$0.0850 1996-12-11 1997-01-15 1997-01-20 1997-01-31 Unknown Regular Quarter
$0.0850 1996-10-09 1996-10-17 1996-10-21 1996-11-01 Unknown Regular Quarter
$0.0850 1996-07-10 1996-07-18 1996-07-22 1996-08-02 Unknown Regular Quarter
$0.0800 1996-04-17 1996-04-25 1996-04-29 1996-05-10 Unknown Regular Quarter
$0.0800 1995-12-13 1996-01-18 1996-01-22 1996-02-02 Unknown Regular Quarter
$0.0800 1995-10-11 1995-10-19 1995-10-23 1995-11-03 Unknown Regular Quarter
$0.0800 1995-07-12 1995-07-20 1995-07-24 1995-08-04 Unknown Regular Quarter
$0.0750 1995-04-19 1995-04-25 1995-05-01 1995-05-12 Unknown Regular Quarter
$0.0750 1994-12-14 1995-01-17 1995-01-23 1995-02-03 Unknown Regular Quarter
$0.0750 1994-10-12 1994-10-18 1994-10-24 1994-11-04 Unknown Regular Quarter
$0.0750 1994-07-13 1994-07-19 1994-07-25 1994-08-05 Unknown Regular Quarter
$0.0700 1994-04-20 1994-04-26 1994-05-02 1994-05-13 Unknown Regular Quarter
$0.0700 1994-01-12 1994-01-18 1994-01-24 1994-02-04 Unknown Regular Quarter
$0.0700 1993-10-13 1993-10-19 1993-10-25 1993-11-05 Unknown Regular Quarter
$0.0700 1993-07-14 1993-07-20 1993-07-26 1993-08-06 Unknown Regular Quarter
$0.0650 1993-04-21 1993-04-27 1993-05-03 1993-05-14 Unknown Regular Quarter
$0.0650 1993-01-13 1993-01-19 1993-01-25 1993-02-05 Unknown Regular Quarter
Company Profile

BCR Company Profile

Exchange: NYSE
Sector: Healthcare

C. R. Bard (BCR) engages in the design, manufacture, packaging, distribution, and sale of medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular, urology, oncology, and surgical specialty products. C. R. Bard sells its products directly and through distributors to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. The company was founded in 1907 and is based in Murray Hill, New Jersey. C.R. Bard is largely affected by quality control and its ability to reduce manufacturing defects, as a defect could have serious consequences on its users. As well, it relies heavily on patent and proprietary rights for its products. C.R. Bard has been increasing its dividend since 1972, and pays its dividend quarterly.

High Yield Stocks

High Yield Stocks

Looking for dividend stocks with great yields? Visit our list of:

High Yield Dividend Stocks
News

C.R. Bard, Inc. News

  • After the bell on Wednesday, a number of big name, dividend paying companies announced their quarterly earnings. Below, we look at these earnings...
  • Over the last month, the S&P 500 Index has shed upwards of 7%; prior to this sell-off, the S&P 500 was up just over 8% for the year. Put...
  • Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its...
  • Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its...
  • Before Wednesday's opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the important analyst...
  • After a few weeks of setting record highs, the markets pulled back today, as the World Bank announced a reduction in its global growth forecast. In...
  • After the bell on Tuesday, a few big name, dividend paying companies announced their quarterly earnings. Below, we look at these earnings reports...
  • Citigroup Raises Price Target on C.R. Bard (BCR)

    Citigroup announced on Monday that it has raised its price target on C.R. Bard, Inc. (BCR) from $123.00 to $124.00. The firm also reiterated its Neutral rating on the company. Commenting on the increased price target, Citigroup analyst Mathew J. Dodds noted "We are adjusting our BCR estimates to reflect the continued delay in the Gore court decision and the completion of the Medafor acquisition. We are now assuming a Gore royalty start in 1Q14 and expect the Medafor acquisition to be slightly EPS accretive in 2014. For 3Q13, we have raised our Soft Tissue Repair estimates due to the full US release of Phasix resorbable mesh." C.R. Bard shares traded 1.01% higher during Monday's session. Year-to-date, the stock is up 16.94%.

    The Bottom Line

    Shares of C.R. Bard, Inc. (BCR) currently yield 0.70% based on Monday's closing price of $120.29 and its annual payout of 84 cents. C.R. Bard, Inc. (BCR)  is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.
    Expand to read the full story
  • C.R. Bard to Acquire Rochester Medical for $262 Million (BCR, ROCM)

    C.R. Bard, Inc. (BCR) announced on Wednesday that it will acquire urine drainage care product company, Rochester Medical Corporation (ROCM). BCR will purchase ROCM for about $262 million, or $20 per share. This acquisition will help BCR expand its urology homecare market. The deal is expected to close later this year. C.R. Bard shares were mostly flat during pre-market trading Wednesday. The stock is up 17% YTD. Rochester Medical shares were up $6.04, or 43.74%, during pre-market trading Wednesday. The stock is up 37% YTD. The Bottom Line Shares of C.R. Bard, Inc. (BCR) have a 0.73% yield, based on Tuesday's closing price of $114.66. C.R. Bard, Inc. (BCR) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.
    Expand to read the full story
  • Bank Of America Boosts Price Target on C.R. Bard, Inc. (BCR)

    Bank of America announced on Thursday that it is maintaining its "Buy" rating on the New Jersey-based medical device manufacturer C.R. Bard, Inc. (BCR) , and also went onto raise its price target for the company. Bob Hopkins, an analyst with the bank, noted that they are raising their price target on C.R. Bard following a meeting with the company's CEO and CFO. Hopkins added that C.R. Bard's financial outlook is promising, noting, "BCR remains broadly out of favor, but we see a clear pathway to accelerating growth and upside to numbers and we view the risk reward on near term catalysts as very favorable. BCR trades at 11.8x our view of BCR's potential 2015 cash earnings power and the average medtech company trades at about 12.3x 2015 cash EPS. We argue BCR is an accelerating growth story with a better than average growth outlook, similar risk and near term catalysts." C.R. Bard shares rallied higher on Thursday, gaining 1.37% on the day. The stock is up 18% YTD. The Bottom Line Shares of C.R. Bard, Inc. (BCR) are yielding 0.73% based on Thursday's closing price of $115.71. C.R. Bard, Inc. (BCR) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.
    Expand to read the full story